Evidence map›Paper›PMID 33419174›Full record

ArticleInternational journal of molecular sciences2021

Crosstalk between Mast Cells and Lung Fibroblasts Is Modified by Alveolar Extracellular Matrix and Influences Epithelial Migration.

Mariam Bagher, Oskar Rosmark, Linda Elowsson Rendin, Annika Nybom, Sebastian Wasserstrom, Catharina Müller, Xiao-Hong Zhou, Göran Dellgren, Oskar Hallgren, Leif Bjermer and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Immunobiology of pulmonary fibrosis.Frontiers in immunology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Store-Operated CaContact (Thousand Oaks (Ventura County, Calif.))
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Mariam BagherUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.ORCID 0000-0001-7594-918X
Oskar RosmarkUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.ORCID 0000-0003-2501-2430
Linda Elowsson RendinUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.
Annika NybomUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.
Sebastian WasserstromLund University Bioimaging Centre, Lund University, 221 85 Lund, Sweden.
Catharina MüllerUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.
Xiao-Hong ZhouBioscience Department, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, 431 53 Mölndal, Sweden.
Göran DellgrenDepartment of Cardiothoracic Surgery and Transplant Institute, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
Oskar HallgrenDepartment of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, 221 85 Lund, Sweden.
Leif BjermerDepartment of Respiratory Medicine and Allergology, Skåne University Hospital, Lund University, 221 85 Lund, Sweden.
Anna-Karin Larsson-CallerfeltUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.ORCID 0000-0001-7586-3896
Gunilla Westergren-ThorssonUnit of Lung Biology, Department of Experimental Medical Sciences, Lund University, 221 84 Lund, Sweden.ORCID 0000-0001-5327-8805
Lund University · SEAstraZeneca (Sweden) · SESahlgrenska University Hospital · SE

Funding

ALF Grants Region Skåne -Alfred Österlunds Stiftelse -Crafoordska Stiftelsen -Evy and Gunnar Sandberg Foundation -Greta and John Kock Foundation -Hjärt-Lungfonden -Lund University Medical Faculty Foundation -Stiftelsen för Strategisk Forskning -The Consul Thure Bergh Foundation -The Royal Physiographic Society in Lund -Vetenskapsrådet 2016-01190Vetenskapsrådet 3R project 2014-2016
6 · The paper itself

Abstract

Mast cells play an important role in asthma, however, the interactions between mast cells, fibroblasts and epithelial cells in idiopathic pulmonary fibrosis (IPF) are less known. The objectives were to investigate the effect of mast cells on fibroblast activity and migration of epithelial cells. Lung fibroblasts from IPF patients and healthy individuals were co-cultured with LAD2 mast cells or stimulated with the proteases tryptase and chymase. Human lung fibroblasts and mast cells were cultured on cell culture plastic plates or decellularized human lung tissue (scaffolds) to create a more physiological milieu by providing an alveolar extracellular matrix. Released mediators were analyzed and evaluated for effects on epithelial cell migration. Tryptase increased vascular endothelial growth factor (VEGF) release from fibroblasts, whereas co-culture with mast cells increased IL-6 and hepatocyte growth factor (HGF). Culture in scaffolds increased the release of VEGF compared to culture on plastic. Migration of epithelial cells was reduced by IL-6, while HGF and conditioned media from scaffold cultures promoted migration. In conclusion, mast cells and tryptase increased fibroblast release of mediators that influenced epithelial migration. These data indicate a role of mast cells and tryptase in the interplay between fibroblasts, epithelial cells and the alveolar extracellular matrix in health and lung disease.

Indexed as

A549 CellsCell CommunicationCell MovementCells, CulturedCoculture TechniquesEpithelial CellsExtracellular MatrixFibroblastsHepatocyte Growth FactorHumansIdiopathic Pulmonary FibrosisInterleukin-6LungMast CellsMicroscopy, Electron, ScanningVascular Endothelial Growth Factor AHepatocyte Growth FactorInterleukin-6Vascular Endothelial Growth Factor Aepithelial cellsextracellular matrixhepatocyte growth factoridiopathic pulmonary fibrosisIL-6lung fibroblastsmast cellstryptasevascular endothelial growth factor

Identifiers

PMID33419174
PMCPMC7825515
OpenAlexW3118995000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.